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Abstract
This paper overviews the problem of the clinical basis, diagno-
sis and available therapy modalities for lymphoedema.  Regard-
ing diagnostics, the measurement of circumference, volume and
thickness of the limb are presented, as well as diagnostic imag-
ing modalities. These include direct and indirect lymphogra-
phy, MRI, CT, ultrasound imaging and lymphoscintigraphy,
which is currently considered the leading technique in primary
diagnosis of lymphoedema and its follow-up. This paper di-
scusses the treatment of lymphoedema and the role of lympho-
scintigraphy in the follow-up of patents with lymphoedema.




Lymphoedema can be defined as the progressive, protein-
rich fluid accumulation in the interstitial spaces of the skin that
arises as a consequence of impaired lymphatic drainage [1, 2].
It can occurr in all parts of the body. However, limbs are most
often affected.
Lymphoedema of the lower or upper extremities is typically
a chronic condition either congenital or acquired. It may be prima-
ry or secondary to the presence of other diseases or occur follo-
wing surgical treatment. The disorder typically affects the dermis
and spares the deeper compartments of the skin. If left untreated
it will continue to progress and becomes irreversible due to the
increased formation of fibres or adipose tissue [2]. Patients with
lymphoedema experience  extremity swelling, decreased coordi-
nation and mobility of joints — mostly elbows, knees and ankles.
Approximately 30% of patients with lymphoedema complain of
pain in the lower and upper limbs [3].
There is a higher risk of infections and injuries. Recurring skin
and subcutaneous tissue inflammations also involve small lym-
phatic vessels. All these disorders lead to an increased risk of
swelling and secondary scarring. Permanent movement disorders,
a feeling of limbs heaviness, the necessity of everyday self-care
management and psychological difficulties can lead to social
changes in patients’ lives [2, 4].
The disease can often be diagnosed by its characteristic cli-
nical presentation, yet, in some cases, ancillary tests might be ne-
cessary to establish the diagnosis, particularly in the early stages
of the disease and in oedemas of mixed etiology [2]. At the initial
medical evaluation of patients with suspected extremity lympho-
edema, it is highly desirable for physicians to define the abnorma-
lity and to establish an objective baseline. Before instituting a the-
rapeutic plan it is very important to determine whether the suspec-
ted abnormality is ideed a lymphatic abnormailty [3, 5–7]. The
differential diagnosis of extremity lymphoedema includes venous
disease and systemic disease (e.g., hypoalbuminemia) [2].
Primary lymphoedema may occur at any phase of life but it most
commonly appears during puberty. Lymphoedema praecox is a spe-
cial type of primary lymphoedema in pediatric patients. It is usually
mild but often impairs quality of life and entails risk of lymphangitis.
Secondary lymphoedema is encountered more often. The
most frequent worldwide cause of lymphoedema is filariasis, which
is particularly common in south-east Asian underdeveloped coun-
tries. In the USA, post-surgical lymphoedema of prevails. Radical
lymphadenectomy or obliteration of lymphatic vessels by scar or
following radiotherapy may lead to lymphoedema after cancer
treatment. It may appear at any time after surgery.
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Lymphoedema is a quite a prevalent disease. Worldwide,
about 90 million people have lymphoedema, primarily because of
parasitic infections. Approximately 10 million people have lym-
phoedema secondary to breast and pelvic cancer therapy, recur-
rent infections, injuries or vascular surgery. When chronic venous
insufficiency is added as a case, there may be as many as
300 million cases [5,8,9]. The reported incidence of secondary
lymphoedema after mastectomy varies amongst different pub-
lished series from 5.5 to 80% reviewed by Szuba and Rockson
[2]. In other studies, it varies between 24–49% [10, 11]. In Europe,
its prevalence is up to 0–60% depending on the mode of breast
cancer treatment and on different methods of measurement and
definition of lymphoedema [12]. Complications of chronic limb
lymphoedema include recurrent cellulitis and lymphangiosarco-
ma. Filarial infestation can cause massive swelling (elephantia-
sis) with associated infection and ulceration.
Rehabilitation is an integral part of lymphoedema treatment. It
helps to minimize and limit the unwanted physical changes such
as decreased mobility and muscle strength. Most patients are
treated conservatively, by means of various forms of compre-
ssion therapy. Prevention is important, as treatment is difficult.
There is no effective pharmacological cure supporting therapy.
Benzopyrones are considered as drugs that can reduce protein-
rich oedema by their influence on proteolysis processes [2]. The
use of diuretics is not recommended. Antibiotics are used to con-
trol the skin infection.
 Surgical treatment is frequently unsuccessful. Lymphatic mi-
crosurgery (lymphatic transplants, lymphatico-venous or lymphat-
ico-lymphatic or lymph node-venous anastomoses) is still in an
experimental stage, although few centres consistently report
favourable outcomes. Volume reducing surgery is performed rare-
ly. A muscular-venous by-pass associated with ultrasound lipo-
suction may be performed [13].
This paper overviews the radionuclide diagnostics in the de-
tection and follow-up of lymphoedema as compared to other dia-




Various clinical classification systems have been developed
to describe the severity of lymphoedema [2]. According to one of
them, there are three clinical stages of lymphatic oedema:
— 1st — reversible oedema. It disappears spontaneously, or when
the limb is elevated;
— 2nd — irreversible oedema. Elevation of a limb does not de-
crease swelling to a considerable extent;
— 3rd — lymphatic elephantiasis with huge increase in size of the
limb and hardened skin [7].
Frequently used objective measures of lymphoedema include
circumferential measures of limbs at various points, volumetric
measurement using limb submersion in water, recording defor-
mation of tissue by mass (tonometry), measurement of impe-
dance (amount of extra cellular water and total water content) and
diagnostic imaging.
Measurement of limb size and shape
 Circumferential measures with calculations designed to com-
pute limb volumes and volumetric measures are used most frequently
in everyday practice, but have some difficulty with reliability [14].
Tape measurement
This method provides information on localization of swelling.
A measurement is made with a tape at marked points on a limb. Re-
sults are referred to values of an unaffected limb. Criteria for identifica-
tion of lymphoedema differ from side-to-side difference of 1, 5 or
2.5 cm even to an increase of 5 cm [15]. Errors are usually caused by
excessive tape-measure pressure on tissues, inaccurate marked points
and improper measuring angle in relation to long axis of the limb [16].
Water displacement volumetry
Water displacement volumetry is a direct measurement of limb
volume submerged in a scaled container of water. Arm lympho-
edema is defined as an increase in volume of 10% or at least 200
ml from the preoperative measurements [15, 17, 18]. However, it
is time-consuming and improper in the case of skin damage and
joint movement limitation [16].
Optoelectronic volumetry
This method is based on the interruption of infrared light beams
by the limb placed inside a special device with rows of infrared
light emitting diodes. The volume is calculated automatically. This
method is probably the most accurate way of limb volume evalu-
ation, but the cost and size of the equipment, difficulty to use it
outside the hospital and impossibility of measurement of the full
length of the limb are major drawbacks [16].
Measurement of the fluid mobility
Tonometry
Tonometry is a method used for the assessment of physical
characteristics of lymphoedema. The clinical pitting test is sub-
jective evaluation made by pressing a finger on the site of the
swelling. Objective determination of the depth of tissue pitting is
provided by using a tonometer, which measures the depth of com-
pression by an applied mass, and is read after a fixed period [16].
Measurement of impedance
Monitoring impedance to a small current passed through the
body might give information about total extra cellular water and
total body water [16]. This method is considered a very useful
tool, especially in early stages of lymphoedema, but fails, when
the swelling is mild. 50% of women after mastectomy with ob-
served increase of limb volume (volumetrically measured) did not
show any changes in bioimpedance measurements [15].
Diagnostic imaging of lymphoedema
Available modalities include contrast lymphography, indirect
lymphography, lymphoscintigraphy, lymphatic capillaroscopy,
magnetic resonance imaging, computed tomography and ultra-
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sonography [2]. Lymphatic capillaroscopy is available only in spe-
cialised centres [2].
Contrast lymphography
Contrast lymphography is accomplished through the direct
injection of iodine based, lipid-soluble contrast media into subcu-
taneous lymphatic vessels, identified prior to the study by subcu-
taneous injection of blue dye. It is an old technique, introduced in
1944 [19] and refined in the nineteen-fifties [20]. Its use has de-
clined recently, superseded by lymphoscintigraphy as a primary
diagnostic tool, although it is still useful in visualizing lymphatic
anatomy prior to lymphatic reconstructive surgery [2]. It is also
carried out in patients, when the lymphoscintigraphy results are
thought to be misleading [21].
Some authors still strongly advocate this technique [22]. They
argue that the unique ability of lymphography to demonstrate de-
rangements of the internal architecture of normal-sized lymph nodes
can be valuable and makes it more accurate than CT in evaluation of
some lymphomas (especially Hodgkin disease) and genitourinary
malignancies. They believe that lymphography and CT are comple-
mentary rather than mutually exclusive techniques for the staging of
some lymphomas and genitourinary malignancies. In addition, lym-
phography opacifies the lymphatic channels and therefore may be a
valuable tool for detection of lymphatic fistulas or lymphatic leakage.
Finally, the authors believe that lymphography helps to guide subse-
quent therapy in patients with lymphomas, genitourinary malignan-
cies, or disorders of lymphatic flow [22]. This may be correct, but
rather in secondary, not primary lymphoedemas.
Additionally, this technique presents many technical difficul-
ties and may exacerbate lymphoedema by the pooling and accu-
mulation of oil-based contrast media.
Indirect lymphography
Indirect lymphography is based upon an intradermal infusion
of water-soluble iodinated contrast media [23]. It is particularly
useful in imaging skin lymphatics and lymphatic trunks. It is useful
both as a primary diagnostic tool and prior to lymphatic recon-
structive surgery.
Magnetic resonance imaging
Magnetic resonance imaging is a useful tool in differential di-
agnosis of limb oedema. In lymphatic oedema, there is a charac-
teristic MRI image of a honeycomb pattern within the epifascial
compartment along with thickening of the skin. In venous oede-
ma, both the epifascial compartments are affected. In lipoedema,
there is a fat accumulation without fluid [25]. Other typical find-
ings are trabecular structures suggesting dilated collateral lym-
phatic vessels in the swollen subcutis [26]. Magnetic resonance
imaging is also useful in lymph node imaging, visualising enlarged
lymphatic trunks and identifying the underlying cases of secondary
lymphoedema. Magnetic resonance imaging of lymphatic vessels
may be enhanced with tissue-specific iron contrast media [27].
Computed tomography
Computed tomography’s (CT) usefulness in diagnosis of lym-
phoedema is rather limited. It provides definition of oedema locali-
sation (subfascial vs. epifascial), identifies skin thickening and the
characteristic honeycomb pattern of the subcutaneous tissue [2, 28].
CT may be useful in monitoring the outcome of compression ther-
apy [29]. Oedema fluid accumulation is readily demonstrated with
a plain CT scan and is not present in lipoedema. Specific CT fea-
tures of the subcutaneous fat and muscle compartments also al-
low accurate differentiation between lymphoedema and deep vein
thrombosis.
Ultrasound examination
Ultrasound examination (US) plays an ancillary role in non-
invasive diagnosis of lymphoedema. It shows the thickening of
the cutaneous, epifascial and subfascial tissue compartments,
interstitial fluid accumulation and sometimes it allows evaluation
of the degree of fibrosis. High frequency ultrasound reveals cha-
racteristic patterns of cutaneous fluid localisation in various types
of oedema [25, 30].
Balzarini et al. showed by US fluid accumulation in 35%, fibro-
sis in 26% and a mixed picture (fibrosis and fluid) in 40%. Correla-
tion with clinical information (”soft,” ”medium,” ”hard”, and
”pitting” oedema) demonstrated that US documented interstitial
fluid in 68.4% of soft oedema, mixed fluid and fibrosis in 64.2% of
medium oedema, and fibrosis in 76.9% of hard oedema. Ultra-
sonography also showed that in soft and medium oedema, fibro-
sis might already have formed [31].
Colour Doppler ultrasound augments the findings of lympho-
scintigraphy, when the two are performed together [32]. There is
an influence of development of fibrosis on US results — subcuta-
neous tissue is more echogenic on the oedematous side, with sig-
nificant hyperechogenicity at the fascial subcutaneous layer, which
indicates that fibrotic tissue develops distally in the forearm [33].
Some findings substantiate the unique role of this modality in
the evaluation of filariasis in secondary lymphoedema. With use
of a standard transducer, Amaral et al [34] were able to detect
indwelling motile adult nematodes in the groins of patients in Re-
cife, Brazil, an endemic area for such parasites.
Fluorescein microlymphangiography
Intradermal injection of fluorescein isothiocyanate dextran
allows visualization of the superficial peripheral microvasculature,
including the contractility, permeability and diffusion characteris-
tics of local blood and lymph capillaries [35, 36]. Diameters of
lymph capillaries can be determined from sequential video-recor-
ded images of the injected field. Findings indicate that patients who
have had lymphoedema since childhood have aplasia of lymphatic
microvessels, whereas those in whom lymphoedema first appears
during puberty (lymphoedema precox) have intact lymphatic ca-
pillaries (initial lymphatic vessels) in conjunction with hypoplastic
lymph trunks more proximally [36].
Lymphoscintigraphy
Today, lymphoscintigraphy is the primary imaging modality
used in determining a diagnosis in patients with suspected ex-
tremity lymphoedema. Lymph node evaluation with radiotracers
dates back to the 1950s [37]. This method has largely replaced
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the more invasive and technically difficult technique of lympho-
graphy [38]. Lymphoscintigraphy has been refined over the past
few decades and has proved reliable and reproducible [2]. The
study is non-invasive with no known adverse effects. In addition,
the radiation dose received during the examination is low, and the
study can be repeated after therapy [5]. Some authors underline
the high sensitivity, but — at least in some cases — insufficient




Early studies were performed using colloidal gold-198 [37].
Due to the high radiation burden this was subsequently replaced
by technetium-99m agents: sulphur, rhenium, stannous sulphur
colloids, antimony sulphide colloid, albumin colloid, microaggre-
gated albumin and human serum albumin [40, 41]. Today, prob-
ably Millipore filtered technetium-99m sulphur colloid is the most
commonly used radiotracer for lymphoscintigraphy, being inex-
pensive, with a very good safety profile and demonstrated clinical
value, although some authors believe (99m)Tc-HIG is marginally
superior to nanocolloid and sulphur colloid for this purpose [41].
Imaging
Most often, 74-296 MBq of 99mTc sulphur colloid suspended in
0.10 ml of saline is injected into the interdigital web spaces be-
tween the first and second digits on the patient’s right and left
lower (or upper) extremities. Intradermal injection is superior to
the subcutaneous [41]. Both of the feet (or hands) are massaged
for 2 minutes immediately after the injection. A high-resolution
collimator is always used. The camera speed is set at 8 cm/min,
and images of at least 300,000 counts are acquired. Images should
be recorded with a dual-head gammacamera, using high-resolu-
tion collimators in whole-body scanning mode and a scan speed
of 10 cm/min [42]. A flow study is performed, and the arrival of
radionuclide delivery to the knees and groin (or to the elbows and
axillary regions for the arms) is timed. Spot and whole-body ima-
ges are obtained for up to 3–4 hr; the study may be also tailored
to the need of individual findings [43]. Quantitative or semi-quan-
titative approach to lymphoscintigraphy may improve the results
of the study [2, 23]. Quantitation of the regional lymph node accu-
mulation of radiotracer is preferred [23].
Normal findings
In patients with normal lymphatic anatomy and function, a pre-
dictable sequence should be seen in lymphoscintigraphy. In the
lower extremities, symmetric migration of the radionuclide should
be seen through discrete lymph vessels (three to five lymph ve-
ssels per calf and one to two per thigh). Then bilateral visualization
of ilioinguinal lymph nodes should occur within 1 hr, as should
visualization of the liver because of the systemic circulation of the
radiocolloid [1, 41, 43]. Typically, approximately one to three
popliteal nodes and two to ten ilioinguinal nodes are visualized
[38]. A parallel sequence should be seen in the upper extremities.
A normal pattern of lymphoscintigraphy is shown in Figure 1.
Abnormal findings
On lymphoscintigrams with abnormal findings, a variety of fin-
dings can be identified, including interruption of lymphatic flow,
collateral lymph vessels, dermal backflow, delayed flow, delayed
visualization or nonvisualization of lymph nodes, a reduced num-
ber of lymph nodes, dilated lymphatics and, in severe cases, no
visualization of the lymphatic system at all [1, 6, 38]. Purely quali-
tative analysis has been reported to be very accurate for confirm-
ing or excluding the diagnosis of lymphoedema, with a sensitivity
as high as 92% and a specificity as high as 100% [1]. An abnor-
mal pattern of lymphoscintigraphy is shown in Figure 2.
Despite earlier reports, most authors believe that primary lym-
phoedema cannot be reliably differentiated from secondary lymphoe-
dema on the basis of lymphoscintigraphic findings alone
[1, 6, 38]. Some authors have reported that lymphoscintigrams of
patients with primary lymphoedema tend to show a lack of lymphatic
vessels and absent or delayed transport, whereas those of patients
Figure 1.  A normal pattern of lymphoscintigraphy of the lower limbs. Figure 2.  An abnormal pattern of lymphoscintigraphy of the lower limbs.
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with secondary lymphoedema tend to show obstruction with visua-
lization of discrete lymphatic trunks and slow transport [5]. In both
primary and secondary lymphoedema, however, both dermal back-
-flow and a decreased number of lymph nodes can be identified [26].
Conservative therapy of lymphoedema
Despite the common opinion about treatment inefficacy, lympho-
edema can and should be treated. The earlier treatment begins after
the onset of the disease the better is the prognosis for the patients
[49]. Treatment is aimed at reducing swelling, educating patients and
families. Decreasing limb swelling improves function and reduces the
risk of infections. Improvement of clinical appearance also has an ad-
vantageous influence on the mental condition of patients [50].
Lymphoedema can be treated in a number of physiotherapy
techniques applied in various combinations.
Complex physical therapy (CPT)
or complete decongestive therapy (CDT)
This method combines lymphatic drainage, compression,
positioning, special exercises and skin care techniques performed
as treatment sessions usually from 2 to 4 or 6 weeks [2, 51]. It is
carried out either as outpatient or inpatient treatment.
Manual Lymph Drainage (MLD)
Manual lymph drainage is focused on draining oedematosus
tissue by stimulating the lymph system, which increases normal-
isation of microlymphatic hypertension and prevents fibrous pro-
cesses in subcutaneous tissue [45, 52]. The massage permits
unblocking of the central lymphatic system and facilitates the lymph
flow from peripheral lymphatics [2]. This procedure should be
carried out by skilled practitioners [53, 54]. The complexity of the
technique requires a special education program and the tech-
nique must be checked constantly.
Bandaging
To continue the stimulation and the shape of the limb after
each session of MLD multilayer bandaging (MLB) is applied. It is
fastened on the wrist area and then a narrow band goes through-
out the dorsal part of the hand to the fingers, binding them up one
by one. Next, a wider bandage binds up the forearm, arm and
shoulder. This way of bandaging permits limb movement and
stretching bandages stimulate lymph flow.
Exercise and positioning
Special exercises are always a part of CPT to supplement the
compression bandages and stimulate lymph drainage by muscu-
lar movement. They are performed 2 or 3 times a day for several
minutes. Leaving a limb in bandages during the exercises is an
advantage. To mobilize lymph flow there should always be breat-
hing exercises included in the program. Negative pressure oscilla-
tions in the chest induce the return of venous blood to the heart
and lymph flow to the venous system [55].
Compression therapy
Once swelling is reduced compression stockings or sleeves
should be applied to prevent re-accumulation of fluid. The degree
of compression ranges from 30–40 mm Hg. Using of a higher
compression is less tolerated by patients [2]. Combining with other
modalities does not increase the reduction of swelling [56]. Other
authors, however, are paying attention to the short term benefits
when this method is used as a primary therapy, emphasizing ben-
efits in reduction achieved after a few months of combined phys-
iotherapy treatment [12].
Education
Systematic patient education is an important element of CPT.
Self-help recommendations to manage lymphoedema include
suitable skin care to prevent deterioration and infection. Tight
clothes, jewellery, airplane flights or even using an elevator may
cause or increase swelling. Proper diet and weight control are
also recommended [57, 15]. Many patients point out strong phys-
ical work as a factor causing or increasing swelling. However,
it has not been shown in many studies [57].
After completion of an intensive 4–6 week regimen of com-
plex therapy, the frequency of the physical treatment sessions
should progressively decrease [58]. The benefits achieved by
physical therapy may decline in time [49, 59].
Intermittent pneumatic compression (IPC)
or sequential intermittent pneumatic
compression (SIPC)
This form of lymphoedema management can be used as
a primary or with the addition of other methods. Exerting tempo-
rary compression during operation with single or multichamber
pneumatic pump facilitates lymphatic drainage and removes fluid
from the extremity. It is reported that forceful fluid displacement
can damage lymphatic-vessels, induce lymphangiitis, increase
swelling and tissue fibrosis [2].
Some studies suggest no efficacy of IPC treatment alone
in the therapy of lymphoedema [60]. Recently Szuba observed
good toleration and no complications after using IPC with ele-
ments of CPT. The reduction of volume was significantly greater
than in the control group only with CPT treatment [61].
The role of lymphoscintigraphy
in the follow-up therapy of lymphoedema
As shown above, lymphoedema is notoriously difficult to treat.
Lymphoscintigraphy can be repeated after therapy to provide an
objective measure of the disease status in patients [5, 45, 46].
Boris et al. reported that 30 patients whose progress was followed
up for as long as 1 year after complex lymphoedema therapy had
an average 86% decrease in their initial extremity volume [44]. Other
authors, however, found no changes in lymphatic flow in patients
treated by sequential intermittent pneumatic compression (SIPC)
and assessed by lymphoscintigraphy. The authors argue that
compression increased the transport of lymph fluid (i.e., water)
without comparable transport of macromolecules (i.e., protein).
Alternatively, SIPC reduced lymphoedema by decreasing blood
capillary filtration (lymph formation) rather than by accelerating
lymph return [47].
Regarding lymphatic surgery, lymphoscintigraphy is also help-
ful, not only in planning microsurgical treatment but also in moni-
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toring the postoperative outcome [48, 62, 63], although some
authors prefer using an ultrasound [64, 65]. Some believe that
lymphoscintigraphy is diagnostic but cannot be repeated frequen-
tly in the follow-up [65], which can be disputed. Lymphoscintigra-
phy as a method of evaluation has proved to be very sensitive,
reproducible and able to measure the transport capacity in fo-
llow-up study in patients with transplanted lymphatic vessels in
upper [48] and lower extremities [62, 63]. In patients 8 years after
microsurgical treatment of lymphatic vessels of an upper extre-
mity, lymphatic function was reported to improve after autologous
lymphatic vessel transplantation compared with preoperative fin-
dings. This could be verified by a statistically significant decrease
of the transport index — TI (< 0.01), clear demonstration of lymph
nodes, and a less diffuse distribution pattern of the Tc-99m-la-
beled nanocolloids [48]. In another study, in 122 investigations of
upper and lower extremities, TI was found to be very sensitive
(97.4%) with specificity 90.3% [62]. Patients with scintigraphic vi-
sualisation of the vessel graft showed a substantially better post-
operative outcome than those without visualisation of the vessel
graft [63]. An important role of lymphoscintigraphy has been also
confirmed in coordinated imaging of the follow up percutaneous
sclerotherapy of lymphangiomas, utilising doxycycline as a scle-
rosant [66].
Some reports deal with the pharmacological treatment of lym-
phoedema. Freedman et al followed-up the efficiency of diethyl-
carbamazine treatment on lymphatic damage in human bancrof-
tian filariasis [67].
Conclusions
There is hope for decreased morbidity of lymphatic oedema
due to the increasing role of selective surgery of lymph nodes, fo-
llowing the sentinel node concept. However, the impact of such
a procedure on the incidence of post surgical lymphoedema has not
been thoroughly assessed yet. On the other hand, the higher inci-
dence of breast cancer and longer survival of patients is likely to
cause increased prevalence of arm lymphoedema, which may deve-
lop many years after surgery. Further studies of early diagnostic
methods, evaluation of lymphoedema over a period of time, deve-
lopment of new therapeutic techniques and finding methods to
assess objectively the effects of therapy are of extreme importance.
These will remain an interesting meeting-point of diagnostic ima-
ging specialists, surgeons and physiotherapists. It will permit better
understanding of physiopathology of lymphoedema, identification
of individual risk factors of swelling in order to undertake preventive
measures of the onset of lymphoedema and ensure appropriate
care, particularly for women treated for breast cancer.
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